Viewing StudyNCT06267274

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 8:07 PM
Last Modification Date: 2024-10-26 @ 3:21 PM
Study NCT ID: NCT06267274
Status: RECRUITING
Last Update Posted: 2024-03-29
First Post: 2024-02-12
Brief Title: A Randomized Double-blind Parallel-group Two-arm Multiple Dose Multicenter Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
Sponsor: Amneal Pharmaceuticals LLC
Organization: Amneal Pharmaceuticals LLC
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Ocular Hypertension
Open-angle Glaucoma
Keywords: